Analyst firms · Argus Research · ANF

Argus Research ANF price target and rating history

Abercrombie & Fitch Company (ANF) · Consumer Discretionary

Argus Research rates Abercrombie & Fitch Company (ANF) Buy with a $162 price target, as of its latest action on Aug 31, 2026. It has published 4 rating actions on ANF since April 2023, including 2 upgrades and 2 downgrades. Across 9 firms with a ANF price target in the last 12 months, the median target is $162. Argus Research's target matches it.

Current rating
Buy
Price target
$162
Median target, all firms
$162
Actions on ANF
4

Argus Research price target on ANF

$162$102$41202420252026
Argus Research price target on ANF, each point a stated target, June 2023 to August 2026.

Every Argus Research rating on ANF

How other firms rate ANF

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Wolfe ResearchOutperform$181Oct 22, 2026
BMO Capital MarketsOutperform$170Sep 9, 2026
Argus ResearchBuy$162Aug 31, 2026
CitigroupNeutral$156Aug 27, 2026
Telsey Advisory GroupOutperform$165Aug 27, 2026
BTIGBuy$175Aug 26, 2026
Raymond JamesMkt PerformAug 18, 2026
BarclaysEqual Weight$114Aug 11, 2026
NeedhamBuy$108Mar 26, 2026
Goldman SachsBuy$120Dec 11, 2025

Questions about Argus Research and ANF

What is Argus Research's price target for ANF?
Argus Research's latest stated price target for Abercrombie & Fitch Company (ANF) is $162, from its action on Aug 31, 2026.
What is Argus Research's rating on ANF?
Argus Research rates ANF Buy, a bullish rating, as of Aug 31, 2026.
When did Argus Research last change its view on ANF?
On Aug 31, 2026, Argus Research upgrades to Buy from Hold, price target $162.
How does Argus Research's ANF target compare with other analysts?
Across 9 firms with a ANF price target in the last 12 months, the median target is $162. Argus Research's target matches it.

More ANF rating histories

All Argus Research ratingsANF news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.